Imported Unlicensed Medicines ("Specials") & NIMPs
Sourcing & Distribution Infrastructure of Unlicensed Medicines & NIMPs
At SUPER B PLUS GROUP LTD®, we specialize in bridging critical supply chain gaps to ensure vital therapies reach healthcare providers, pharmacies, and clinical research networks across Great Britain. Operating under our active MHRA Wholesale Distribution Authorisation License WDA(H) 56111, we provide end-to-end management of the procurement, rigorous regulatory gatekeeping, and seamless delivery of Imported Unlicensed Medicines ("Specials") and Clinical Trial Supplies—including Non-Investigational Medicinal Products (NIMPs)—sourced directly from approved territories.
When a critical therapeutic formulation is unavailable or discontinued within the domestic UK framework, patients and clinicians rely on targeted sourcing pipelines. We implement rigid validation loops for every single imported pack. This preserves total data integrity, confirms batch authenticity, and ensures that treating clinics, national hospital trusts, and authorized supply chain partners can procure critical therapies safely.
Our Specialized Sourcing Lines
-
Imported Unlicensed Medicines (Specials): When a UK-licensed medicine faces an acute supply shortage, discontinuation, or when an individual patient requires a specific formulation, we utilize established networks to ethically source equivalent authorized products from approved markets.
-
Clinical Trial Supply Management (NIMPs & Comparators): We partner with clinical trial sponsors and Contract Research Organisations (CROs) to secure commercial background therapies, active comparators, and rescue medications (NIMPs) from approved countries, maintaining absolute batch-specific documentation and lot integrity.
-
Comprehensive Product Support: We assist clinical and procurement teams by securing essential medical validation documentation, including English Summary of Product Characteristics (SmPCs), detailed product summary sheets, and tracking robust patient safety protocols.
Compliance-Led Value: Over-Labelling & Translation Services
Under the Human Medicines Regulations, unlicensed imports must be entirely safe for UK clinicians and patients to handle. SUPER B PLUS GROUP LTD® coordinates an integrated quality ecosystem to deliver end-to-end localization and remediation services:
-
English Language Over-Labelling: Foreign language packs are processed seamlessly through accredited GMP manufacturing pathways where they are physically over-labeled in English to display required UK storage warnings, dosage markers, and crucial safety text.
-
Translated Patient Information Leaflets (PILs): We orchestrate the internal insertion of fully translated English PILs inside the primary packaging, ensuring absolute compliance with institutional clinical expectations before final distribution.
-
Batch Verification & Release: Every modified batch undergoes a rigorous checking loop and formal validation before transitioning to our domestic UK GDP distribution network.
Why Choose SUPER B PLUS GROUP LTD®?
-
Total Regulatory Peace of Mind: Governed by an exhaustive Quality Management System, we coordinate and execute the entire 28-day MHRA Notification of Intent to Import process internally, ensuring a formal "No Objection" notification is secured before any product enters circulation.
-
End-to-End Cold Chain Integrity: Continuous, data-logged temperature-monitored distribution vectors ( to and to ) safeguard the product from the point of origin to final delivery.
-
Advanced GDP Logistics Network: Strategic alignment between international supply pathways, localized GMP remediation facilities, and our authorized storage hubs at Riverside Business Centre, Tilbury, guarantees full inventory traceability.
👥 Who We Serve
In alignment with UK healthcare regulations, we do not supply the general public directly for restricted lines. Our import, remediation, and distribution channels are strictly tailored for authorized professional buyers:
-
NHS and Private Hospital Pharmacies
-
Registered Wholesale Distributors
-
Clinical Trial Sponsors and Contract Research Organisations (CROs)
-
Independent Community Pharmacies